Gord Fishell is a professor and associate director of the NYU Neuroscience Institute, which he was central in creating as a founding member. His laboratory is interested in the developmental steps that allow the startling repertoire of inhibitory GABAergic interneurons to integrate in the brain. As the link between interneurons and psychiatric disease has become more apparent, his work has increasingly spanned the boundary between development and disease. This is a logical extension of his scientific career, which for the past 20 years has bridged the fields of developmental genetics and physiology. This experience has fomented his strong belief that a genetic understanding of interneurons will lead to novel treatments for psychiatric disease. Dr. Fishell’s interest in development began during his PhD in the neurobiology program at the University of Toronto. He did a postdoctoral fellowship at Columbia University before going on to a brief 2-year stint as an assistant professor at the Rockefeller University. He then joined the newly founded Skirball Developmental Genetics Program at the NYU Medical Center in 1994 and remained there for 10 years until he founded the Smilow Neuroscience program, which in 2012 merged with the NYU Neuroscience institute. Dr. Fishell has been a Simons Investigator since 2007, gave a Society of Neuroscience Presidential Lecture in 2014, and is the recipient of the Merson and Shucart prizes. He is a standing member of the Novartis FMI advisory board and is on the council of NIH’s National Institute of Neurological Disorders and Stroke.
« Go Back